603983 Stock Overview
Engages in the research and development, design, production, sale, and service of various cosmetics in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Guangdong Marubi Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥32.99 |
| 52 Week High | CN¥36.82 |
| 52 Week Low | CN¥20.17 |
| Beta | 0.22 |
| 1 Month Change | -0.33% |
| 3 Month Change | 10.78% |
| 1 Year Change | 11.49% |
| 3 Year Change | 20.36% |
| 5 Year Change | -46.75% |
| Change since IPO | 11.53% |
Recent News & Updates
Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital
Dec 25
Calculating The Fair Value Of Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983)
Dec 09Is Now The Time To Put Guangdong Marubi Biotechnology (SHSE:603983) On Your Watchlist?
Nov 22Recent updates
Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital
Dec 25Calculating The Fair Value Of Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983)
Dec 09Is Now The Time To Put Guangdong Marubi Biotechnology (SHSE:603983) On Your Watchlist?
Nov 22Market Participants Recognise Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Earnings Pushing Shares 27% Higher
Sep 26Guangdong Marubi Biotechnology's (SHSE:603983) Promising Earnings May Rest On Soft Foundations
Aug 30Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital
Jun 19Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet
May 29Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?
May 07Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion
Mar 27Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around
Feb 29Shareholder Returns
| 603983 | CN Personal Products | CN Market | |
|---|---|---|---|
| 7D | 2.0% | -0.08% | 0.07% |
| 1Y | 11.5% | -2.2% | 18.4% |
Return vs Industry: 603983 exceeded the CN Personal Products industry which returned -3.2% over the past year.
Return vs Market: 603983 underperformed the CN Market which returned 15.4% over the past year.
Price Volatility
| 603983 volatility | |
|---|---|
| 603983 Average Weekly Movement | 6.5% |
| Personal Products Industry Average Movement | 5.8% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in CN Market | 10.8% |
| 10% least volatile stocks in CN Market | 4.0% |
Stable Share Price: 603983 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603983's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 1,101 | Huaiqing Sun | www.marubi.cn |
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company provides skin care, make up, and eye care products. It offers its products under the Marubi, Lianhuo, Chunji, and the Love Fire brand names.
Guangdong Marubi Biotechnology Co., Ltd. Fundamentals Summary
| 603983 fundamental statistics | |
|---|---|
| Market cap | CN¥13.23b |
| Earnings (TTM) | CN¥324.39m |
| Revenue (TTM) | CN¥2.64b |
40.8x
P/E Ratio5.0x
P/S RatioIs 603983 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603983 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.64b |
| Cost of Revenue | CN¥712.64m |
| Gross Profit | CN¥1.93b |
| Other Expenses | CN¥1.60b |
| Earnings | CN¥324.39m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 26, 2025
| Earnings per share (EPS) | 0.81 |
| Gross Margin | 73.02% |
| Net Profit Margin | 12.28% |
| Debt/Equity Ratio | 7.3% |
How did 603983 perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield94%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/29 06:09 |
| End of Day Share Price | 2025/01/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangdong Marubi Biotechnology Co., Ltd. is covered by 23 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Lei Yang | CGS International |
| Jin Li | Changjiang Securities Co. LTD. |
| Lei Yang | China Galaxy International Securities (Hong Kong) |